As of 2025-06-16, the Relative Valuation of Sarepta Therapeutics Inc (SRPT) is 6.17 USD. This relative valuation is based on P/E multiples. With the latest stock price at 36.18 USD, the upside of Sarepta Therapeutics Inc based on Relative Valuation is -83.0%.
The range of the Relative Valuation is (34.62) - 50.52 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 14.0x | 13.8x |
| Forward P/E multiples | 13.2x - 15.1x | 14.2x |
| Fair Price | (34.62) - 50.52 | 6.17 |
| Upside | -195.7% - 39.6% | -83.0% |
| Date | P/E |
| 2025-06-13 | -14.32 |
| 2025-06-12 | -14.76 |
| 2025-06-11 | -14.96 |
| 2025-06-10 | -15.46 |
| 2025-06-09 | -15.71 |
| 2025-06-06 | -17.02 |
| 2025-06-05 | -15.51 |
| 2025-06-04 | -15.64 |
| 2025-06-03 | -15.38 |
| 2025-06-02 | -14.93 |
| 2025-05-30 | -14.88 |
| 2025-05-29 | -15.28 |
| 2025-05-28 | -14.73 |
| 2025-05-27 | -15.17 |
| 2025-05-23 | -15.00 |
| 2025-05-22 | -15.35 |
| 2025-05-21 | -15.85 |
| 2025-05-20 | -15.82 |
| 2025-05-19 | -15.01 |
| 2025-05-16 | -14.41 |
| 2025-05-15 | -13.96 |
| 2025-05-14 | -14.14 |
| 2025-05-13 | -14.32 |
| 2025-05-12 | -14.39 |
| 2025-05-09 | -14.35 |
| 2025-05-08 | -14.45 |
| 2025-05-07 | -14.53 |
| 2025-05-06 | -18.50 |
| 2025-05-05 | -25.19 |
| 2025-05-02 | -25.13 |
| 2025-05-01 | -24.84 |
| 2025-04-30 | -24.69 |
| 2025-04-29 | -24.08 |
| 2025-04-28 | -24.34 |
| 2025-04-25 | -23.91 |
| 2025-04-24 | -24.44 |
| 2025-04-23 | -23.54 |
| 2025-04-22 | -23.47 |
| 2025-04-21 | -21.85 |
| 2025-04-17 | -21.28 |
| 2025-04-16 | -21.34 |
| 2025-04-15 | -21.53 |
| 2025-04-14 | -21.62 |
| 2025-04-11 | -20.19 |
| 2025-04-10 | -19.91 |
| 2025-04-09 | -22.02 |
| 2025-04-08 | -19.51 |
| 2025-04-07 | -20.73 |
| 2025-04-04 | -21.54 |
| 2025-04-03 | -23.19 |